Q3213221 (Q3213221): Difference between revisions
Jump to navigation
Jump to search
(Created a new Item) |
(Changed label, description and/or aliases in en) |
||
| description / en | description / en | ||
Project | Project Q3213221 in Spain | ||
Revision as of 03:15, 9 October 2021
Project Q3213221 in Spain
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q3213221 in Spain |
Statements
1,570,783.2 Euro
0 references
1,963,479.0 Euro
0 references
80.0 percent
0 references
5 June 2019
0 references
30 November 2021
0 references
BIOQUOCHEM SL
0 references
33035
0 references
En concreto, durante la ejecución de este proyecto se trata de investigar en una novedosa metodología de análisis de peróxido de hidrogeno como indicador de la evolución de pacientes tras sufrir un ACV, ya que ha sido descrito en la bibliografía, que tanto la actividad de la enzima catalasa (CAT- biomarcador dependiente de H2O2) como la actividad de la enzima glutatión peroxidasa (GPx- utiliza H2O2 como cofactor) son mayores en pacientes isquémicos, comparados con individuos sanos.Además, la Catalasa puede ser considerada como un marcador de la evolución positiva de pacientes tras sufrir un ACV. (Spanish)
0 references
Specifically, during the execution of this project, it is a question of investigating in a novel methodology of hydrogen peroxide analysis as an indicator of the evolution of patients after suffering a stroke, since it has been described in the literature that both the activity of the catalase enzyme (H2O2-dependent biomarker) and the activity of the glutathione peroxidase enzyme (GPx- uses H2O2 as a cofactor) are greater in ischemic patients, compared to healthy individuals. In addition, Catalase can be considered as a marker of the positive evolution of patients after suffering a stroke. (English)
0 references
Llanera
0 references
Identifiers
IDE/2019/000335
0 references